Visión generalGráficoNoticiasTraderScreen

BVT Put 920 LLY 20.06.2025/  DE000VD9JMU4  /

Frankfurt Zert./VONT
12/11/2024  19:59:38 Diferencia+1.090 Bid21:59:44 Ask21:59:44 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
12.870EUR +9.25% -
Volumen de oferta: -		 -
Tamaño/ Volumen/ Formato de Ask: -		 ELI LILLY 920.00 - 20/06/2025 Put
TeleTrader 30/10 US opens lower after earnings, jobs, GDP data
TeleTrader 30/10 Eli Lilly's Q3 revenue up 20% to $11.4 billion
TeleTrader 11/10 Eli Lilly's obesity drug nears approval in Japan, CEO confirms
TeleTrader 02/10 Eli Lilly to commit $4.5 billion in a new Indiana facility
Newsfile Corp 17/09 Precision Healthcare Innovator Brian Meshkin and Leading Litigation Law Firm, Plante Huguenin Lebovi...
Newsfile Corp 16/09 Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer
Newsfile Corp 11/09 Les FNB Harvest (TSX : LLYH, LLYH.U, AMZH, AMZH.U, MSFH, MSFH.U, NVDH, NVDH.U, LLHE, LLHE.U, AMHE, A...
Newsfile Corp 11/09 Harvest ETFs (TSX: LLYH, LLYH.U, AMZH, AMZH.U, MSFH, MSFH.U, NVDH, NVDH.U, LLHE, LLHE.U, AMHE, AMHE....
Newsfile Corp 11/09 Statistiques de financement par actions du Groupe TMX pour août 2024
TeleTrader 09/09 Eli Lilly appoints Lucas Montarce as CFO
GlobeNewswire 03/09 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
Newsfile Corp 28/08 The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire 27/08 Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2024 Corporate Membership...
GlobeNewswire 26/08 Eliem Therapeutics Announces Additions to its Leadership Team
GlobeNewswire 21/08 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 21/08 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 19/08 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 14/08 Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s ...
GlobeNewswire 14/08 Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD...
TeleTrader 09/08 US trades up premarket after yesterday's earnings
TeleTrader 08/08 Wall Street rallies at close, Dow soars 680 pts
GlobeNewswire 08/08 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...
TeleTrader 08/08 US opens higher with data, earnings in focus
GlobeNewswire 08/08 ProQR Announces Second Quarter 2024 Operating and Financial Results
TeleTrader 08/08 Eli Lilly's Q2 revenue jumps 36% to $11.3B